A doctor shares her own experience losing 50kg with GLP-1 medications like Wegovy, Ozempic, Mounjaro and Zepbound.
Recap by typeshit. Post by @drwhitetalksabout on Instagram.
8:09
Regan Archibald gives his take on the timeline for retatrutide reaching patients. Tap through for his view on where the drug stands.
Morse says bar and restaurant workers have seen younger adults drink less, framing it as a broad change in the alcohol industry.
Bazaar India's new issue looks at collagen loss and skin laxity concerns tied to fast GLP-1 weight loss, and how beauty brands are responding.
Novo also reported 25% average weight loss in women on CagriSema in a post-hoc trial analysis, while BMO flagged Ozempic losing US share.
8:32
Archibald follows up his earlier retatrutide video with a look at its uses. Retatrutide is still an investigational drug and is not FDA approved.
A shared research summary evaluating how GLP-1 receptor agonists affect deaths and hospital stays in people with type 2 diabetes. Details are thin here.
Loading…